CRISPR vs Gene Therapy for Sickle Cell: Which Treatment Works Better? Introduction Sickle cell disease (SCD) remains one of the most prevalent inherited hematologic disorders globally, affecting millions of individuals across diverse populations. It is estimated that approximately 100,000 people in the United States live
Tag: SCD
New Frontiers in Sickle Cell Disease: CRISPR-Based Cures
New Frontiers in Sickle Cell Disease: CRISPR-Based Cures Abstract Sickle cell disease (SCD) remains one of the most pressing global health challenges, with an estimated 300,000 infants born annually with the disorder and millions more living with its lifelong complications. The burden of SCD is disproportionately higher in